Xueguang Zhang mainly investigates Immune system, Pathology, Immunology, Cancer research and Internal medicine. His study in Immune system is interdisciplinary in nature, drawing from both Cancer cell, Interleukin 12 and Cell biology. The various areas that Xueguang Zhang examines in his Immunology study include Clinical uses of mesenchymal stem cells, Amniotic epithelial cells, Adult stem cell and Polysaccharide.
His research integrates issues of microRNA, Prostate-specific antigen, Prostate cancer, Hyperplasia and Multiple myeloma in his study of Cancer research. His studies in Internal medicine integrate themes in fields like Endocrinology, Oncology and Gene expression profiling. His Immunohistochemistry research includes elements of PD-L1, Pathological and Adenoma.
Molecular biology, Immunology, Cancer research, Immune system and T cell are his primary areas of study. His research in Molecular biology intersects with topics in Cell culture, Transfection, Monoclonal antibody and Antigen. His Immunology research incorporates themes from Internal medicine and Clinical significance.
Xueguang Zhang focuses mostly in the field of Cancer research, narrowing it down to topics relating to Cancer and, in certain cases, Oncology and Pathology. His specific area of interest is Immune system, where Xueguang Zhang studies CD8. His T cell study combines topics from a wide range of disciplines, such as Tumor microenvironment and Cell biology.
His primary areas of study are Cancer research, Immunology, Immune system, Molecular biology and Cell. His biological study spans a wide range of topics, including Cancer cell, Cancer, Colorectal cancer, Gene knockdown and PI3K/AKT/mTOR pathway. His work on T cell, CD28 and IL-2 receptor as part of his general Immunology study is frequently connected to Hepatitis B virus, thereby bridging the divide between different branches of science.
His Immune system research is multidisciplinary, incorporating perspectives in Immunohistochemistry and Neuromyelitis optica. His studies deal with areas such as Cell culture, Angiogenesis, Antibody, Monoclonal antibody and B-cell activating factor as well as Molecular biology. His Cell research includes themes of Apoptosis, Stem cell and Cell growth.
Xueguang Zhang mostly deals with Cancer research, Immunology, T cell, Immune system and Cancer cell. His Cancer research research integrates issues from Tumor microenvironment, PD-L1, CD8 and Colorectal cancer. Xueguang Zhang has researched Immunology in several fields, including Hepatocellular carcinoma, Internal medicine and Clinical significance.
His Internal medicine research is multidisciplinary, relying on both CD28, Adoptive cell transfer and Interleukin 21. His work deals with themes such as Transforming growth factor, Cellular differentiation, PI3K/AKT/mTOR pathway and Janus kinase, which intersect with T cell. His biological study spans a wide range of topics, including Immunohistochemistry, Cell, Infiltration and Uicc stage.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Generation of gene-modified mice via Cas9/RNA-mediated gene targeting.
Bin Shen;Jun Zhang;Hongya Wu;Jianying Wang.
Cell Research (2013)
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
Chuan-Yong Mu;Jian-An Huang;Ying Chen;Cheng Chen.
Medical Oncology (2011)
Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance
Changping Wu;Yibei Zhu;Jingting Jiang;Jiemin Zhao.
Acta Histochemica (2006)
Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells
Zongning Miao;Jun Jin;Lei Chen;Jianzhong Zhu.
Cell Biology International (2006)
TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.
Xin Gao;Yibei Zhu;Yibei Zhu;Gang Li;Haitao Huang.
PLOS ONE (2012)
TOXICOLOGICAL CHARACTERISTICS OF NANOPARTICULATE ANATASE TITANIUM DIOXIDE IN MICE
Yanmei Duan;Jie Liu;Linglan Ma;Na Li.
Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines.
Yongjing Chen;Qin Wang;Bimin Shi;Ping Xu.
Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells
Xin Gao;Xuefeng Wang;Qianting Yang;Xin Zhao.
Journal of Immunology (2015)
IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells
Qianting Yang;Gang Li;Gang Li;Yibei Zhu;Yibei Zhu;Lin Liu.
European Journal of Immunology (2011)
Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B;Zhang Xg;Jourdan M;Boiron Jm.
European Cytokine Network (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: